These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3409580)

  • 41. Diaphragm weakness in Charcot-Marie-Tooth disease.
    Laroche CM; Carroll N; Moxham J; Stanley NN; Evans RJ; Green M
    Thorax; 1988 Jun; 43(6):478-9. PubMed ID: 3420560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients.
    Don R; Serrao M; Vinci P; Ranavolo A; Cacchio A; Ioppolo F; Paoloni M; Procaccianti R; Frascarelli F; De Santis F; Pierelli F; Frascarelli M; Santilli V
    Clin Biomech (Bristol, Avon); 2007 Oct; 22(8):905-16. PubMed ID: 17686557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple arthrodesis in the treatment of fixed cavovarus deformity in adolescent patients with Charcot-Marie-Tooth disease.
    Mann DC; Hsu JD
    Foot Ankle; 1992 Jan; 13(1):1-6. PubMed ID: 1577335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication.
    Berciano J; Gallardo E; García A; Pelayo-Negro AL; Infante J; Combarros O
    J Neurol; 2011 Sep; 258(9):1594-602. PubMed ID: 21590514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment and management of pes cavus in Charcot-Marie-tooth disease.
    Alexander IJ; Johnson KA
    Clin Orthop Relat Res; 1989 Sep; (246):273-81. PubMed ID: 2766615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric Charcot-Marie-Tooth disease type 1A.
    Burns J; Scheinberg A; Ryan MM; Rose KJ; Ouvrier RA
    Muscle Nerve; 2010 Aug; 42(2):262-7. PubMed ID: 20544937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical management of pes cavus deformity with an underlying neurological disorder: a case presentation.
    Hewitt SM; Tagoe M
    J Foot Ankle Surg; 2011; 50(2):235-40. PubMed ID: 21354011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tibialis posterior insufficiency occurring in a patient without peronei: a mechanical etiology.
    Kohls-Gatzoulis JA; Singh D; Angel JC
    Foot Ankle Int; 2001 Dec; 22(12):950-2. PubMed ID: 11783918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soft tissue surgery in Charcot-Marie-Tooth disease.
    Roper BA; Tibrewal SB
    J Bone Joint Surg Br; 1989 Jan; 71(1):17-20. PubMed ID: 2914996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttraumatic cavovarus deformity of the foot.
    Carroll KL; Shea KG; Stevens PM
    J Pediatr Orthop; 1999; 19(1):39-41. PubMed ID: 9890284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Surgical management of anterior cavas foot in Charcot-Marie-Tooth patients. Five-year follow-up].
    Parra-Tellez P; Hernández-González JL; López-Gavito E; Vázquez-Escamilla J
    Acta Ortop Mex; 2015; 29(2):97-102. PubMed ID: 27012083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of appropriate ankle-foot orthoses models for patients with Charcot-Marie-Tooth disease.
    Guillebastre B; Calmels P; Rougier PR
    Am J Phys Med Rehabil; 2011 Aug; 90(8):619-27. PubMed ID: 21681059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foot drop correction: by active dorsiflexion or tenodesis effect? Commentary on an article by T. Dreher, MD, et al.: "Tibialis posterior tendon transfer corrects the foot drop component of cavovarus foot deformity in Charcot-Marie-Tooth disease".
    Aronow MS
    J Bone Joint Surg Am; 2014 Mar; 96(6):e50. PubMed ID: 24647517
    [No Abstract]   [Full Text] [Related]  

  • 54. Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication.
    Berciano J; García A; Combarros O
    Muscle Nerve; 2003 Jan; 27(1):34-9. PubMed ID: 12508292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical considerations in the presence of Charcot-Marie-Tooth disease.
    Fenton CF; Schlefman BS; McGlamry ED
    J Am Podiatry Assoc; 1984 Oct; 74(10):490-8. PubMed ID: 6491142
    [No Abstract]   [Full Text] [Related]  

  • 56. [Carbamazepine-sensitive neuromyotonia and Charcot-Marie-Tooth disease of the neuronal type].
    Serratrice G; Pouget J; Pellissier JF; Cros D
    Rev Neurol (Paris); 1989; 145(12):867-8. PubMed ID: 2694289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long term results of the revisited Meary closing wedge tarsectomy for the treatment of the fixed cavo-varus foot in adolescent with Charcot-Marie-Tooth disease.
    Simon AL; Seringe R; Badina A; Khouri N; Glorion C; Wicart P
    Foot Ankle Surg; 2019 Dec; 25(6):834-841. PubMed ID: 30482439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postural instability in Charcot-Marie-Tooth 1A disease.
    Tozza S; Aceto MG; Pisciotta C; Bruzzese D; Iodice R; Santoro L; Manganelli F
    Gait Posture; 2016 Sep; 49():353-357. PubMed ID: 27491052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hindfoot varus and neurologic disorders.
    Krause FG; Iselin LD
    Foot Ankle Clin; 2012 Mar; 17(1):39-56. PubMed ID: 22284551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Charcot-Marie-Tooth's disease with severe trophic and sensory disorders. Study of a case following along a half a century with anatomical studies.
    Barraquer-Bordas L; Navarro C; Salisachs P
    Acta Neurol Latinoam; 1981; 27(3-4):177-89. PubMed ID: 6965173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.